Department of Health Administrative Order No. 2020-0017

Notifying member
Philippines
Title
Department of Health Administrative Order No. 2020-0017
First published
21/05/2020
First EIF
05/06/2020
Latest published
In force to
Latest notification
G/LIC/N/2/PHL/201
List of products subject to licensing

30PHARMACEUTICAL PRODUCTS

Nature of licensing

Non-automatic

Administrative purpose/measure being implemented
  • Other
Decription of purpose/measure being implemented

To simplify the requirements and processes for initial, renewal and variation to License to Operate. Inclusion of drug products in the coverage as it has the same procedural guidelines as the medical devices following DOH AO No. 2020-0017.

Administrative body(ies) for submission of applications
Food and Drug Administration
1781 Civic Dr, Alabang, Muntinlupa, 1781 Metro Manila
https://www.fda.gov.ph
+63288571900

info@fda.gov.ph

Contact point for information on eligibility

Same as the "Administrative bodies"

Expected duration of licensing procedure
Ongoing
Found by secretariat
No
Related document symbols
  • G/LIC/N/2/PHL/189
Source
Notes
  • Procedural Guidelines repealing AO No.2016-0003


  • G/LIC/N/2/PHL/189

    DOH Administrative Order No.2020-0017
    – Revised Guidelines on the Unified Licensing Requirements and Procedures of the Food and Drug Administration Repealing AO No.2016-0003


    9033.00.00 - Parts and accessories (not specified or included elsewhere in Chapter 90) for machines, appliances, instruments or apparatus of Chapter 90.


    Initial, renewal and variation to License to Operate for Traders and Distributors (Wholesalers/Importers/Exporters) of:


    All medical devices, Radiation-emitting devices, In-vitro diagnostic device and reagents, Refurbished medical devices, Equipment or devices used for treating sharps, Pathological and infectious waste, Water treatment devices/systems, And other health-related devices as determined by the FDA.


    The said issuance redefined the coverage of activities and establishment regulated by the FDA and repealed AO No. 2016-0003.


  • G/LIC/N/2/PHL/201


    DOH Administrative Order No. 2020-0017 – Revised Guidelines on the Unified Licensing Requirements and Procedures of the Food and Drug Administration Repealing AO No. 2016-0003


    Modification: Other: Inclusion of drug products in the coverage as it has the same procedural guidelines as the medical devices following DOH AO No. 2020-0017.


    DOH AO No. 2020-0017 was already notified to the WTO for medical devices. Since the procedural guidelines for drug products and medical devices are similar, there is a need to update the N2 Notification for DOH AO No. 2020-0017 to include drug products as follows:


    Drugs


    HS 30 Pharmaceutical products


    Initial, renewal and variation to License to Operate applications of Manufacturers (including packers/repackers), Traders, Distributors (as importers, exporters, and/or wholesalers), drug outlets such as drugstores, pharmacies (community, hospital or institutional) or boticas, and retail outlets for non-prescription drugs (RONPDs) of all drugs including vaccines, biologics, veterinary medicines, and animal health products, medical gases, traditional medicine, and herbal medicine.